NO923280L - Nye oraltvirkende elastaseinhibitorer - Google Patents

Nye oraltvirkende elastaseinhibitorer

Info

Publication number
NO923280L
NO923280L NO92923280A NO923280A NO923280L NO 923280 L NO923280 L NO 923280L NO 92923280 A NO92923280 A NO 92923280A NO 923280 A NO923280 A NO 923280A NO 923280 L NO923280 L NO 923280L
Authority
NO
Norway
Prior art keywords
elastase inhibitors
new oral
oral effective
effective elastase
new
Prior art date
Application number
NO92923280A
Other languages
English (en)
Other versions
NO923280D0 (no
NO308999B1 (no
Inventor
Norton Paul Peet
Michael Richard Angelastro
Joseph Paul Burkhart
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO923280D0 publication Critical patent/NO923280D0/no
Publication of NO923280L publication Critical patent/NO923280L/no
Publication of NO308999B1 publication Critical patent/NO308999B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO923280A 1991-08-22 1992-08-21 Nye, kjemiske forbindelser, og farmasøytisk preparat inneholdende disse NO308999B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74860791A 1991-08-22 1991-08-22

Publications (3)

Publication Number Publication Date
NO923280D0 NO923280D0 (no) 1992-08-21
NO923280L true NO923280L (no) 1993-02-23
NO308999B1 NO308999B1 (no) 2000-11-27

Family

ID=25010166

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923280A NO308999B1 (no) 1991-08-22 1992-08-21 Nye, kjemiske forbindelser, og farmasøytisk preparat inneholdende disse

Country Status (16)

Country Link
EP (1) EP0529568B1 (no)
JP (1) JP3311392B2 (no)
KR (1) KR100242046B1 (no)
AT (1) ATE147756T1 (no)
AU (1) AU655831B2 (no)
CA (1) CA2076307C (no)
DE (1) DE69216713T2 (no)
DK (1) DK0529568T3 (no)
ES (1) ES2099186T3 (no)
FI (1) FI923787A (no)
GR (1) GR3022915T3 (no)
HU (1) HU208703B (no)
IL (1) IL102858A (no)
NO (1) NO308999B1 (no)
NZ (1) NZ243998A (no)
ZA (1) ZA926185B (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
NZ254503A (en) * 1992-07-29 1996-08-27 Merrell Dow Pharma Peptide pulmonary surfactants and compositions thereof
WO1994003484A1 (en) * 1992-07-31 1994-02-17 Merrell Dow Pharmaceuticals Inc. Synthetic peptide lung surfactants having covalently bonded antioxidants
US5977074A (en) * 1993-10-01 1999-11-02 Merrell Pharmaceuticals, Inc. Inhibitors of β-amyloid protein production
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5484772A (en) * 1994-03-04 1996-01-16 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
US5488037A (en) * 1994-03-04 1996-01-30 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
CA2183428A1 (en) * 1994-03-11 1995-09-14 John J. Baldwin Sulfonamide derivatives and their use
EP0763055B1 (en) * 1994-06-02 1999-11-03 Merrell Pharmaceuticals Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
DE69522940T2 (de) * 1994-06-02 2002-04-04 Merrell Pharma Inc Acylierte enolderivate als vorläufdrogen von elastaseinhibitoren
ATE246708T1 (de) * 1994-06-02 2003-08-15 Aventis Pharma Inc Elatase-inhibitoren
US5618792A (en) * 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US20020119985A1 (en) 1994-11-21 2002-08-29 Albert Gyorkos Serine protease inhibitors
US6001813A (en) * 1994-11-21 1999-12-14 Cortech Inc. Val-pro containing α-keto oxadiazoles as serine protease inhibitors
US6001814A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors
US6001811A (en) * 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors--N-substituted derivatives
US6150334A (en) * 1994-11-21 2000-11-21 Cortech, Inc. Serine protease inhibitors-tripeptoid analogs
US6100238A (en) * 1994-11-21 2000-08-08 Cortech Inc. Indole and tetrahydroisoquinoline containing Alpha-keto oxadiazoles as serine protease inhibitors
US6015791A (en) * 1994-11-21 2000-01-18 Cortech Inc. Serine protease inhibitors-cycloheptane derivatives
US6159938A (en) * 1994-11-21 2000-12-12 Cortech, Inc. Serine protease inhibitors comprising α-keto heterocycles
US5998379A (en) * 1994-11-21 1999-12-07 Cortech Inc. Serine protease inhibitors-proline analogs
US5691368A (en) * 1995-01-11 1997-11-25 Hoechst Marion Roussel, Inc. Substituted oxazolidine calpain and/or cathepsin B inhibitors
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
KR100343553B1 (ko) * 1995-03-23 2002-10-31 에스케이케미칼주식회사 열가소성폴리에테르에스테르블록공중합체조성물
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US6656910B2 (en) 1997-12-04 2003-12-02 Cortech, Inc. Serine protease inhibitors
MXPA00011312A (es) * 1998-05-20 2003-04-22 Expression Genetics Inc Un vehiculo de gen polimerico de poli-l.lisina injertada con polietilenglicol con porcion de enfoque hepatocitos.
WO1999062538A1 (en) 1998-06-03 1999-12-09 Cortech Inc. Alpha-keto oxadiazoles as serine protease inhibitors
WO2013152170A1 (en) 2012-04-04 2013-10-10 Catylix, Inc. Selective androgen receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318318A1 (en) * 1987-11-27 1989-05-31 Sensititre Limited Urine assay process and kit
CA2077665A1 (en) * 1990-03-05 1991-09-06 Robert Siman Chymotrypsin-like proteases and their inhibitors
EP0480044A4 (en) * 1990-03-30 1993-06-09 Japan Tobacco Inc. Novel 4h-3,1-benzoxazin-4-one derivative

Also Published As

Publication number Publication date
AU655831B2 (en) 1995-01-12
IL102858A (en) 1998-12-27
JPH05213991A (ja) 1993-08-24
AU2106592A (en) 1993-02-25
CA2076307A1 (en) 1993-02-23
ATE147756T1 (de) 1997-02-15
DE69216713T2 (de) 1997-05-28
FI923787A0 (fi) 1992-08-21
KR930004280A (ko) 1993-03-22
EP0529568A1 (en) 1993-03-03
HU208703B (en) 1993-12-28
EP0529568B1 (en) 1997-01-15
FI923787A (fi) 1993-02-23
DK0529568T3 (da) 1997-02-03
GR3022915T3 (en) 1997-06-30
ZA926185B (en) 1993-03-01
CA2076307C (en) 2003-01-07
ES2099186T3 (es) 1997-05-16
IL102858A0 (en) 1993-01-31
JP3311392B2 (ja) 2002-08-05
HUT62014A (en) 1993-03-29
NO923280D0 (no) 1992-08-21
NZ243998A (en) 1994-11-25
DE69216713D1 (de) 1997-02-27
KR100242046B1 (ko) 2000-03-02
NO308999B1 (no) 2000-11-27

Similar Documents

Publication Publication Date Title
NO923280L (no) Nye oraltvirkende elastaseinhibitorer
ATE361288T1 (de) N-(3,-dimethylindolin-6-yl)ä2-ä(4-
NL300175I2 (nl) Methylsulfonylfenyl-2-(5H)-furanonen als remmers van COX-2.
LV12209A (lv) Ar fenilgrupu aizvietoti heterocikli ka ciklooksigenazes-2 inhibitori
ATE189218T1 (de) Bicyclische diarylheterocyclen als cyclooxygenase-2-inhibitoren
DE60228761D1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
DK0805796T3 (da) Celleadhæsionsinhiberende forbindelser
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
ATE227293T1 (de) 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
PT705100E (pt) Guanidinas substituidas terapeuticas
DE69522945D1 (de) Verbindungen, die als antiproliferative mittel und als garft inhibitoren verwendbar sind
IS7616A (is) Frumuviðloðunarbælandi bólgueyðandi og ónæmisbælandi efnasambönd
NO934218L (no) Inhibitorer av cathepsin g og elastase for forhindring av bindevevsned-brytning
NO944946D0 (no) Forgrenet-amino-substituerte tiazoler, fremgangsmåter for fremstilling av dem og farmasöytiske blandinger inneholdende dem
IL113940A (en) Synthetic peptides which are elastase inhibitors and pharmaceutical compositions for the treatment of neutrophil associated inflammatory disease containing said inhibitors
DE69715173T2 (de) Bisarylcyclobutenderivate als cyclooxygenasehemmer
NO20053726L (no) Forbindelser med prolyloligopeptidase-hemmende aktivitet
TR200001026T2 (tr) Nötrofil elastaz inhibitörü olarak pirolopirolon türevleri.
HUP9902417A2 (hu) Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai
RU93058386A (ru) Противовирусная комбинация, содержащая неуклеозидный аналог, фармацевтическая композиция, способ лечения
BR9510257A (pt) Monômeros ciclohexan-1-óis 4,4-(di-substituidos) e compostos relacionados
ITMI931174A0 (it) Composizioni farmaceutiche per la cura della talassemia
ITMI911930A0 (it) Composizioni farmaceutiche di stereoisomeri di ossiracetam e loro impiego terapeutico